✦ LIBER ✦

Impact of age on outcome of pediatric acute myeloid leukemia : A report from 2 institutions

✍ Scribed by Bassem I. Razzouk; Elihu Estey; Stanley Pounds; Shelly Lensing; Sherry Pierce; Mark Brandt; Jeffrey E. Rubnitz; Raul C. Ribeiro; Michael Rytting; Ching-Hon Pui; Hagop Kantarjian; Sima Jeha

Book ID: 102106827
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 147 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21892

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of treatment on the outcome of ac

Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution’s experience

✍ Razzouk, B I; Raimondi, S C; Srivastava, D K; Pritchard, M; Behm, F G; Tong, X; 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Acute myeloid leukemia as a second malig

Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina

✍ Felice, Maria S.; Zubizarreta, Pedro A.; Chantada, Guillermo L.; Alfaro, Elizabe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

Background. Acute myeloid leukemia (AML) is well-recognized as one of the most important second malignancies. We report the occurrence of secondary AML (sAML) in our institution. Procedure. From September 1987 to August 1996 we have observed sAML in 9 patients (median age 4 years), 5 of them previo

Homoharringtonine as a backbone drug for

Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China

✍ JingYan Tang; Yin Liu; Jing Chen; Huiliang Xue; Ci Pan; LongJun Gu 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 248 KB

Impact of genetic variation in FKBP5 on

Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study

✍ Mitra, A K; Crews, K; Pounds, S; Cao, X; Downing, J R; Raimondi, S; Campana, D; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 184 KB

Expression of TGF-β receptor ALK-5 has a

Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

✍ Otten, J; Schmitz, L; Vettorazzi, E; Schultze, A; Marx, A H; Simon, R; Krauter, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 501 KB

In vivo expression of survivin and its s

In vivo expression of survivin and its splice variant survivin-2B: Impact on clinical outcome in acute myeloid leukemia

✍ Mandy Wagner; Karin Schmelz; Christian Wuchter; Wolf-Dieter Ludwig; Bernd Dörken 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB 👁 1 views

## Abstract Survivin, a member of the inhibitor of apoptosis protein family, is expressed in most human cancers, but undetectable in normal differentiated adult tissue __in vivo__. Because of this cancer‐related expression, survivin is a promising target for cancer therapy. To determine the express